INIS
accounting
16%
assessments
10%
capacity
16%
chlorpromazine
14%
clinical trials
16%
comparative evaluations
23%
cytochromes
10%
data
10%
design
17%
dose equivalents
14%
doses
28%
drugs
30%
enzymes
76%
genotype
83%
liver
17%
management
16%
patients
100%
phenotype
78%
populations
10%
psychoses
100%
range
20%
reviews
50%
risks
27%
serotonin
16%
side effects
83%
size
10%
symptoms
33%
tools
10%
units
10%
values
16%
Keyphrases
Antipsychotics
14%
Aripiprazole
50%
Clinical Effect
50%
Cochrane
7%
CYP2C19
50%
Cytochrome P450 2D6 (CYP2D6)
100%
Cytochrome P450 Enzymes
7%
Google Scholar
7%
Healthy Volunteers
7%
Hepatic Cytochrome P450
7%
High Risk
7%
Methodological Issues
7%
Multiple Measurements
7%
Neurological Effects
7%
Newcastle
7%
Pediatric Samples
7%
Pharmacogenetic Study
14%
Pharmacogenetics
10%
Phenoconversion
50%
Poor Metabolizer
10%
Psychiatric Unit
7%
Psychosis
50%
Psychotic Disorders
10%
Risk of Bias
7%
Risk of Bias Tool
7%
Risperidone
55%
Selective Genotyping
7%
Statistical Power
7%
Treatment Outcome
10%
Web of Science
7%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
16%
Aripiprazole
50%
Chlorpromazine
33%
Clozapine
16%
CYP2C19
50%
CYP2D6
50%
Cytochrome P450
7%
Normal Human
7%
Pharmacogenetics
64%
Population Study
7%
Psychosis
50%
Randomized Controlled Trial
7%
Risperidone
100%
Side Effect
50%
Typical Antipsychotic
14%
